Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve To consider and approve ....

SHUKRA PHARMACEUTICALS LTD. 30th July,2026 The General Manager-Listing Corporate Relationship Department The BSE Limited Ground Floor, PJ Towers, Dalal Street, Mumbai-400001 Securitv Code: 524632 Dear Sir/Madam, Sub: Intimation of Board Meetins pursuant to Resulation 29 of SEBI (Listins Oblisations and Disclosure Requirements) Resulations. 20L5 Pursuant to Regulation2g read with other applicable Regulation of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on llrh August,2026 at the Registered Office of the Company inter alia to consider and approve the following: - 1. Unaudited hnancial result for the Quarter ended on 30th June, 2026 along with the Auditor's Limited Review Report. 2. Any other business with the permission of Chairman. Please take the same on your record and oblige. Thanking you, Yours faithfully, For Shukra Ph Limited Ritu Kapoor Director DIN:10334249 Cl N : L2423LGI1993PLC0 L9O7 Regd, Office : 3rd Floor, "VEER HOUSE" Opp. WIAA Office, Judges Bunglow Road, Bodakdev Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, lndia, Ph. :02754-2863L7 Email : info@shukrapharmaceuticals.com I Website : www.shukrapharmaceuticals.com